鸿茅药业鲍东奇：守正创新，双轨共进：鸿茅药业的中医药现代化思考与实践

Core Viewpoint - The biopharmaceutical industry is at a pivotal moment as it transitions into the "15th Five-Year Plan," emphasizing the need for a balance between traditional practices and innovative approaches to ensure sustainable growth in the face of technological and capital cycles [1][2]. Group 1: Industry Context - The biopharmaceutical sector is experiencing rapid technological iterations, rational capital returns, and a deep restructuring of the global competitive landscape [2]. - The year 2026 is anticipated to be crucial for the integration of traditional Chinese medicine (TCM) into modern health practices, moving from confidence in heritage to a conscious engagement with contemporary scientific frameworks [8][9]. Group 2: Company Strategy - Hongmao Pharmaceutical, with nearly 300 years of history, aims to explore new paths for TCM development by balancing tradition and innovation, emphasizing the importance of both "guarding the essence" and "innovation" [1][2]. - The company is committed to modern clinical research to support traditional practices, transitioning TCM from experience-based to evidence-based approaches [4][5]. Group 3: Innovation and Technology - Hongmao is transforming from "manufacturing" to "intelligent manufacturing," utilizing digital traceability to ensure the authenticity of medicinal materials and implementing smart manufacturing for precision in processes [5][6]. - The integration of advanced technologies, such as artificial intelligence and real-world evidence, is seen as essential for developing a comprehensive evidence system from raw materials to clinical applications [9]. Group 4: Cultural Heritage and Industry Development - The company is focused on converting cultural heritage into industrial momentum, promoting standardized cultivation and traceability of medicinal materials while enhancing product quality through modern technology [6][7]. - The approach of "cultural empowerment of industry" aims to enhance brand competitiveness and inject vitality into local development, ensuring that cultural heritage serves contemporary needs [6][10]. Group 5: Future Outlook - The future of TCM is envisioned as a systemic reconstruction that roots itself in ancient wisdom while addressing modern health challenges, with a focus on preventive health measures [8][9]. - Hongmao aims to evolve from merely supplying products to empowering health, creating a comprehensive health service ecosystem that integrates medicine, health, and culture [7][9].